We are live on
!
Find out more
BBL
Beck Bode LLC Portfolio holdings
AUM
$660M
Turnover
45.93%
1-Year Est. Return
36.73%
This Fund
S&P 500
This Quarter
Est. Return
+13.52%
1 Year Est. Return
+36.73%
3 Year Est. Return
+155.13%
5 Year Est. Return
+202.18%
10 Year Est. Return
–
AUM
$490M
AUM Growth
+$43.8M
(+9.8%)
Cap. Flow
+$7.38M
Cap. Flow
% of AUM
1.51%
Top 10 Holdings %
Top 10 Hldgs %
29.68%
Holding
143
New
24
Increased
29
Reduced
53
Closed
35
Avg Time Held
0.9
years
Top 10 Avg Time Held
0.3
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boyd Gaming
BYD
|
+$15.1M |
| 2 |
Microsoft
MSFT
|
+$11.5M |
| 3 |
PG&E
PCG
|
+$9.86M |
| 4 |
Progressive
PGR
|
+$9.13M |
| 5 |
Oscar Health
OSCR
|
+$9.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$11.7M |
| 2 |
Marriott International
MAR
|
+$11.7M |
| 3 |
Entergy
ETR
|
+$10.3M |
| 4 |
Corpay
CPAY
|
+$9.94M |
| 5 |
CSX Corp
CSX
|
+$8.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Utilities | 24.5% |
| 2 | Technology | 20.11% |
| 3 | Miscellaneous | 11.56% |
| 4 | Healthcare | 9.68% |
| 5 | Consumer Discretionary | 9.49% |
Similar funds
PCA
EIP
FSC
PIFP
BMWS
WFA
PL
WCP
Beck Bode LLC's Q1 2024 Portfolio in Review
As of Q1 2024, Beck Bode LLC held 143 positions worth $490M, up 9.8% from $446M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Beck Bode LLC's Q1 2024 filing shows 24 new, 29 increased, 53 reduced and 35 closed positions. Its largest new stake was Boyd Gaming: 237,450 shares worth $16M. The largest sale was Vertex Pharmaceuticals, an estimated $11.7M.
By sector, the portfolio is most concentrated in Utilities at 25% of assets, up from 24% a quarter earlier, followed by Technology and Miscellaneous.
- Beck Bode LLC's largest Q1 2024 buy was Boyd Gaming: 237,450 shares worth $16M.
- Beck Bode LLC added most to Microsoft in Q1 2024, an estimated $11.5M increase.
- Beck Bode LLC's biggest Q1 2024 reduction was Apple, cutting an estimated $3.05M.
- Beck Bode LLC fully exited Vertex Pharmaceuticals in Q1 2024, selling an estimated $11.7M.
- Beck Bode LLC's ten largest holdings make up 30% of its $490M portfolio in Q1 2024.
- Beck Bode LLC opened 24 new positions and closed 35 in Q1 2024.
- Beck Bode LLC's portfolio value rose 9.8% quarter-over-quarter to $490M.
Based on Beck Bode LLC's 13F filing for Q1 2024, filed 22 May 2024.